Nyrada Inc Health Care
Biotech Healthcare

$0.028 -0.001 (-3.45%)

High $0.03	Low $0.03	Trades 20	Turnover $17,485	Volume 622,600
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code NYR	Name Nyrada Inc	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 247,092,830	Shares Floated 129,946,367	Held by Insiders 47.707%	Held by Institutions 0.437%

Directors & Officers

Name & Education	Position
Mr. James Bonnar	CEO, MD & Director
Mr. Cameron Peter Jones C.A.	Chief Financial Officer
Mr. Benjamin Evison Ph.D.	Chief Scientific Officer
Mr. Dimitri Burshtein	Investor Relations Manager
Mr. Mark Waring B.Sc., P.M.P.	Senior Vice President of US Operations
Mr. David James Franks BEc, C.A., F Fin, J.P.	Company Secretary
Jasneet Parmar	Director of Research & Development
Dr. Alex Suchowerska	Director of Clinical Development & Regulatory Affairs

NYR Historic Dividends

Date	Amount
We found no dividends on record for NYR.

End of Day Prices

Date	Close	Volume	Change
31-Jul	$0.64	572,126	+0.09 (15.32%)
30-Jul	$0.56	70,306	+0.02 (2.78%)
29-Jul	$0.54	245,457	+0.02 (3.85%)
28-Jul	$0.52	224,743	-0.03 (5.45%)
27-Jul	$0.55	211,586	+0.01 (1.85%)
24-Jul	$0.54	150,277	-0.02 (2.70%)
23-Jul	$0.56	132,351	+0.02 (3.74%)
22-Jul	$0.54	579,786	-0.03 (6.14%)
21-Jul	$0.57	292,641	+0.03 (5.56%)
20-Jul	$0.54	550,136	+0.02 (3.85%)
17-Jul	$0.52	184,364	+0.24 (82.46%)
18-Sep	$0.29	469,304	+0.02 (7.55%)
12-Sep	$0.27	1,219,674	-0.01 (3.64%)
11-Sep	$0.28	328,460	-0.02 (5.17%)
05-Sep	$0.29	445,172	+0.02 (7.41%)
10 up, 5 down, and 0 flat days

Market Cap (31-Jul) $154,433,024	EBITDA -	PE 0.00	Book Value $0.04
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.02	Profit Margin N/A
Operating Margin -415.57%	ROA 41.98%	ROE 71%	Revenue (FY) $2,379,126
Revenue per Share $0.01	Gross Profit (FY) $-1,846,743	Q' YOY Revenue Growth 2.2%	Q' YOY Earnings Growth -

Nyrada Inc Health Care
Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NYR Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Nyrada Inc Health Care Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NYR Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Nyrada Inc Health Care
Biotech Healthcare